Resuming Coverage on PetVivo (PETV).

After Being up 1,035%, Raising $11 Million, Upgrading to NASDAQ, and Retreating 87% From its High, we Resume Coverage.
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
ehave,

Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

Contactless Health Screening Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
Drone Stock Review. Draganfly

Draganfly (DPRO) Shareholder Call Today, 4PM EST.

https://youtu.be/SwKfEfKi8rU Shareholder update call today August 12, 2021 at 2PM MST / 4PM EST.
Biotech Stock Review, DYAI

Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).

Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal. We've had...
Drone Stock Review, Cameron Chell

Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

Closes $20 Million Raise.Uplists to NASDAQ.Pilot Training for First Responders Firefighters, Search and Rescue Commences.Reports Record Revenues for Second Quarter.Shareholder Update and...

Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy

VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...
Draganfly, Drone Stock Review

Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.

Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a...

With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?

Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF). TRADING AT THE LOWER END OF...
Psychedelic Stock Review

Are Psychedelics the New Prozac?

Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...